FDA Adverse Event Injury Summary report: N

GORE EXCLUDER AAA ENDOPROSTHESIS

MDR report key: 3122505 · Received May 15, 2013

Report

Report Number
2017233-2013-00309
Event Type
Injury
Date Received
May 15, 2013
Date of Event
March 26, 2013
Report Date
April 22, 2013
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P020004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

REFER TO THE FOLLOWING MEDWATCH REPORT FOR THE INFORMATION REGARDING THE CONFORMABLE GORE TAG THORACIC ENDOPROSTHESIS: 2017233-2013-00310.

Description of Event or Problem · 1

ON AN UNKNOWN DATE IN 2005, THE PATIENT UNDERWENT TREATMENT OF A TYPE A DISSECTION USING AN ELEPHANT TRUNK TECHNIQUE. IT WAS REPORTED, THE DISSECTION EXTENDED DISTALLY INTO ONE OF THE EXTERNAL ILIAC ARTERIES. ON AN UNKNOWN DATE IN 2011, THE PATIENT UNDERWENT ENDOVASCULAR REPAIR OF AN ABDOMINAL AORTIC ANEURYSM AND FALSE LUMEN REPERFUSION. A 31 MM GORE EXCLUDER AAA ENDOPROSTHESIS TRUNK-IPSILATERAL LEG COMPONENT WAS IMPLANTED WITH A 45 MM CONFORMABLE GORE TAG THORACIC ENDOPROSTHESIS EXTENDING PROXIMALLY. ON (B)(6) 2013, A FOLLOW-UP COMPUTED TOMOGRAPHY SCAN SHOWED FILLING OF THE FALSE LUMEN FROM PROXIMAL SEPTAL TEARS. IT WAS REPORTED, THE ANEURYSM WAS NOTED TO BE INCREASING IN SIZE AND MEASURED 6.2 CM. ON (B)(6) 2013, AN INTERVENTION WAS PERFORMED TO TREAT THE FALSE LUMEN PERFUSION OF THE ABDOMINAL AORTIC ANEURYSM. A CONFORMABLE GORE TAG DEVICE WAS IMPLANTED PROXIMALLY, AND A SECOND TAG DEVICE WAS PLACED DISTALLY FROM THE PROXIMAL ELEPHANT TRUNK TO THE ABDOMINAL STENT GRAFT AFTER COMPLETE VISCERAL DEBRANCHING. COMPLETION ANGIOGRAPHY SHOWED NO EVIDENCE OF ENDOLEAK, AND THE PATIENT TOLERATED THE PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
214471 GORE EXCLUDER AAA ENDOPROSTHESIS MIH/SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| R DIAZEPAM| METOPROLOL